Key facts
- This page summarizes FIL Ltd's Form 4 filing for Bicara Therapeutics Inc. (BCAX).
- 6 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 18 Sep 2024, 11:54.
FIL Ltd - 16 Sep 2024 Form 4 Insider Report for Bicara Therapeutics Inc. (BCAX)
- Reporting relationship
- Other*
- Issuer ticker
- BCAX
- Reported as of
- 16 Sep 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Sep 2024, 11:54:57 UTC
- Prior SEC filing
- 12 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FIL Limited, Eight Roads Shareholdings Limited, and its direct and indirect subsidiaries, Eight Roads Holdings Limited and Eight Roads GP
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
FIL Ltd filed Form 4 for Bicara Therapeutics Inc. (BCAX) on 18 Sep 2024.
Change
- Previous filing in this sequence was filed on 12 Sep 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BCAX
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +54,092
- Change %
- Price
- Shares after
- 54,092
- Date
- 16 Sep 2024
- Ownership
- Eight Roads Ventures India Healthcare IV, L.P.
- Footnotes
- F1
BCAX
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +606,885
- Change %
- +1122%
- Price
- Shares after
- 660,977
- Date
- 16 Sep 2024
- Ownership
- Eight Roads Ventures India Healthcare IV, L.P.
- Footnotes
- F1
BCAX
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +352,876
- Change %
- +53%
- Price
- Shares after
- 1,013,853
- Date
- 16 Sep 2024
- Ownership
- Eight Roads Ventures India Healthcare IV, L.P.
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BCAX
transaction
Derivative
Series Seed Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -54,092
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 16 Sep 2024
- Ownership
- Eight Roads Ventures India Healthcare IV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 54,092
- Exercise price
- Footnotes
- F1
BCAX
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -606,885
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 16 Sep 2024
- Ownership
- Eight Roads Ventures India Healthcare IV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 606,885
- Exercise price
- Footnotes
- F1
BCAX
transaction
Derivative
Series C Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -352,876
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 16 Sep 2024
- Ownership
- Eight Roads Ventures India Healthcare IV, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 352,876
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
FIL Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
On September 16, 2024, in connection with the completion of the issuer's initial public offering, each share of Series Seed, B, and C Preferred Shares converted on a 1-for-1 basis into shares of Common Stock.
SEC remarks
Remark 1: Eight Roads Shareholdings Limited ("ERSL") and Pandanus Partners, LP ("Pandanus") own voting stock of Eight Roads Holdings Limited ("ERHL"). ERHL is the indirect parent company of Eight Roads GP ("ERGP") which is the ultimate general partner of the limited partnership which owns the shares being reported on with this Form. The percentage of total voting power represented by ERSL and Pandanus shares of ERHL voting stock may fluctuate due to changes in the total number of shares of ERHL voting stock outstanding from time to time, ERSL's holdings represents more than 50% and Pandanus' holding represents more than 25% and less than 50% of, the total votes which may be cast by all holders of ERHL voting stock. The shares in ERSL are owned primarily by officers and senior employees of FIL Limited and Eight Roads together with several charitable organizations. No such person or organization owns or controls more than 25% of the voting stock in ERSL. Pandanus Associates, Inc. ("PAI") acts as general partner of Pandanus. Pandanus is owned by trusts for the benefit of members of the Johnson family, including ERHL's Chairman Abigail P. Johnson, but disclaims that any such member is a beneficial owner of the securities reported on this form. The address of ERSL, ERHL and ERGP is 42 Crow Lane, Pembroke HM19, Bermuda. The address of Pandanus is c/o FIL Ltd, 42 Crow Lane, Pembroke HM19, Bermuda. The address of PAI is 11 Keewaydin Drive, Suite 100, Salem, NH, USA, 03079. Eight Roads Ventures India Healthcare IV, L.P is a limited partnership ("ERVI HC"). The General Partners of ERVI HC is Eight Roads Ventures India Healthcare Advisors IV, L.P. ("ERVI HCA"). The general partner of ERVI HCA is ERGP, which is ultimately controlled by ERSL. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein.